Yüklüyor......
The clinical promise of immunotherapy in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous disease with poorer outcomes compared to other breast cancer subtypes. Contributing to the worse prognosis in TNBC is the higher rates of relapse and rapid progression after relapse. Advances in targeted therapeutics and conventional chemothera...
Kaydedildi:
| Yayımlandı: | Cancer Manag Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292225/ https://ncbi.nlm.nih.gov/pubmed/30573992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S185176 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|